Gene · 2217
Papers4,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRn. | Int J Mol Sci | 2026 | 41828601 | PubTator, text mining | PubMed |
| Indirect Comparison of Nipocalimab Versus Efgartigimod and Rozanolixizumab in the Treatment of Generalized Myasthenia Gravis. | Adv Ther | 2026 | 41817915 | PubTator, text mining | PubMed |
| The conserved human astrovirus-receptor interface reveals a targetable vulnerability for antiviral development. | Nat Commun | 2026 | 41813687 | PubTator, text mining | PubMed |
| Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. | J Blood Med | 2026 | 41809517 | PubTator, text mining | PubMed |
| Late-Onset Ocular Myasthenia Gravis-Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report. | Biologics | 2026 | 41808843 | PubTator, text mining | PubMed |
| Computational modelling of the equine arteritis virus GP5/M Dimer: Implications for immune evasion and virulence. | PLoS One | 2026 | 41805756 | PubTator, text mining | PubMed |
| Morvan Syndrome Masquerading as Anxiety Disorder: A Case Report Highlighting the Importance of Recognizing Organic Signs in Psychiatric Settings. | Int Med Case Rep J | 2026 | 41800271 | PubTator, text mining | PubMed |
| Advances in IL-2 Family Cytokine-Based Cancer Therapies: Overcoming Challenges Through Molecular Engineering and Delivery Strategies. | Immune Netw | 2026 | 41800025 | PubTator, text mining | PubMed |
| In vivo Expansion of Regulatory T cells via an Engineered IL-2 Mutein to Suppress Autoimmune Glomerulonephritis. | Theranostics | 2026 | 41799211 | PubTator, text mining | PubMed |
| Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody-Drug Conjugates Bearing DXd as a Cytotoxic Payload. | ACS Omega | 2026 | 41799094 | PubTator, text mining | PubMed |
| Implications and prospects of immunological and neuroimaging research in HIV-associated neurocognitive disorders. | Front Neurol | 2026 | 41798804 | PubTator, text mining | PubMed |
| Maternal immunization and early-life immunity: Mechanisms shaping neonatal protection. | Vaccine | 2026 | 41797174 | PubTator, text mining | PubMed |
| Fetal and neonatal alloimmune thrombocytopenia (FNAIT): From reactive transfusion to proactive prevention. | Eur J Obstet Gynecol Reprod Biol | 2026 | 41791326 | PubTator, text mining | PubMed |
| Anti-HPA-1a fetal-neonatal alloimmune thrombocytopenia: reframing diagnostics, pathophysiology, and management. | Blood | 2026 | 41779743 | PubTator, text mining | PubMed |
| Distinct Antibody Fc-profiles in Lymph During Homeostasis and Chronic HIV Infection. | Pathog Immun | 2026 | 41778254 | PubTator, text mining | PubMed |
| Integrative structural insights into the IgG-FcRn interactions revealed by engineered FcRn-immobilized affinity chromatography. | Commun Biol | 2026 | 41776316 | PubTator, text mining | PubMed |
| Non-sensorimotor symptoms in chronic inflammatory demyelinating polyneuropathy. | J Neurol | 2026 | 41774214 | PubTator, text mining | PubMed |
Rapid Symptomatic Improvement and Long-Term Minimal Symptom Expression in a Myasthenia Gravis Patient Treated With Zilucoplan Without Maintenance Cholinesterase Inhibitors, Corticosteroids, or Immunosuppressants: A Case Report. | Cureus | 2026 | 41769457 | PubTator, text mining | PubMed |
| Emergency use of eculizumab in impending and manifest myasthenic crisis: a retrospective case series. | Ther Adv Neurol Disord | 2026 | 41769309 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | 41768137 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2217/papers?page=8